What is Happy Ring?

Happy Ring: FDA-cleared + service-gated ring archetype

Happy Ring is a service-gated FDA-cleared smart ring biometric from Happy Health. Per DEPLOY's biometric cluster framework, Happy Ring anchors the FDA-cleared + service-gated ring archetype within the ring sub-cohort: the genuinely-FDA-cleared sleep-apnea anchor within DEPLOY's ring sub-cohort, distinct from RingConn AHI-claimed-not-cleared + Ultrahuman FibriCheck-third-party-AFib verification postures.

TWO dated FDA 510(k) clearances: K240236 + K242224

Per Agent A Wave 3 biometric ingest, Happy Ring holds two dated FDA 510(k) clearances:

• K240236 (October 8, 2024): REMOTE MONITORING clearance. NOT 'screening' per Agent A correction. The remote-monitoring clearance scope is the verified scope; trade-press coverage framing K240236 as 'screening' clearance operates outside Agent A primary-source-anchored verification.
• K242224 (June 18, 2025): HOME SLEEP TEST DIAGNOSIS SUPPORT clearance. Ages 22+. Clinician-directed (NOT autonomous diagnosis per Agent A correction). The clinician-directed-vs-autonomous distinction matters editorially: K242224 supports clinician diagnosis workflow; the device does NOT autonomously diagnose sleep apnea.

Per cap-flag-as-trust-signal, the two-clearance precision matters editorially at the FDA-verification layer: K240236 monitoring vs K242224 diagnosis-support are structurally distinct clearance scopes; clinician-directed-vs-autonomous distinction at K242224 prevents misframing as "the ring diagnoses sleep apnea." The dated 510(k) clearances are load-bearing primary-source verification anchors.

Per DEPLOY's framework, Happy Ring's dual-clearance posture creates the sharp within-cohort verified-vs-claimed counterpoint to RingConn: same form factor (smart ring), similar capability claims (sleep apnea detection), diametrically opposite verification posture. RingConn AHI 90.7%-claimed but NOT FDA-cleared with company PR explicit "actively pursuing clearance." Happy Ring: dual FDA 510(k) clearances dated 2024 + 2025. The within-cohort pair operates recursively on the verified-vs-claimed framework: canonical framework worked example.

Service-gated availability: NO retail price

Per Agent A Wave 3 biometric ingest, Happy Ring is sold only bundled into insurer-billed Happy Sleep service: NO retail price. Per cap-flag-as-trust-signal, the service-gated framing is honest-absence on consumer pricing: the Happy Ring is not available for direct consumer purchase; the Happy Sleep service bundles ring hardware + clinician workflow + insurance billing into integrated sleep-apnea diagnosis-support delivery.

Per DEPLOY's framework, the service-gated archetype is structurally distinct from other ring sub-cohort entries: RingConn $279 subscription-free retail + Ultrahuman ~$349 + subscription + Oura purchase + membership all operate as direct-consumer products; Happy Ring operates as integrated clinical-service infrastructure.

$60M Series A August 2022; commercially active across 48 states (CORRECTED from "quiet since 2022")

Per Agent A Wave 3 biometric ingest + re-verify sweep, Happy Health raised $60M Series A in August 2022. The "quiet since 2022" framing in Agent A's own earlier Wave 3 framing was incorrect; Agent A's re-verify sweep CORRECTED the framing: Happy Health is commercially active across 48 states with OpenLoop + EnsoData service infrastructure.

Per DEPLOY's framework, the self-correction matters editorially at the verified-vs-claimed framework integrity layer: even Agent A's framings undergo re-verification; the 48-state commercial-activity + OpenLoop + EnsoData service infrastructure is the load-bearing verified state. The two FDA clearances (K240236 Oct 2024 + K242224 Jun 2025) post-date the $60M Series A August 2022 and align with the commercially-active 48-state state per Agent A re-verify sweep.

97% PSG agreement company-reported (no peer-reviewed citation)

Per Agent A Wave 3 biometric ingest, Happy Ring company-reports 97% PSG (polysomnography) agreement for the home sleep test diagnosis-support clearance. Per cap-flag-as-trust-signal, no peer-reviewed citation supports the 97% PSG agreement figure per Agent A primary-source verification.

Per DEPLOY's framework, the company-reported-vs-peer-reviewed distinction matters editorially: 97% PSG agreement is company-reported, load-bearing at the company-claim verification posture; peer-reviewed verification operates at higher verification posture pending peer-review publication. Trade-press coverage framing the 97% PSG figure at peer-reviewed verification posture operates outside Agent A primary-source-anchored verification.

"Brain biometrics" UNSUBSTANTIATED by named EEG hardware

Per Agent A Wave 3 biometric ingest, Happy Ring's "brain biometrics" marketing is UNSUBSTANTIATED by named EEG hardware. Per cap-flag-as-trust-signal, the cap-flag matters editorially: the "brain biometrics" marketing claim is NOT supported by primary-source-anchored EEG-hardware verification; the ring does not contain named EEG hardware components per Agent A primary-source verification.

Per DEPLOY's framework, the marketing-claim-vs-hardware-verification cap-flag is editorial signal at the marketing-claim verification layer: trade-press coverage that frames "Happy Ring brain biometrics" without EEG-hardware substantiation operates outside Agent A primary-source-anchored verification.

Cohort positioning: FDA-cleared + service-gated ring archetype

Per the biometric cluster framework, Happy Ring anchors:

• FDA-cleared + service-gated ring archetype: dual K240236 + K242224 clearances; service-gated availability via Happy Sleep insurer-billed service.
• Sharp within-cohort verified-vs-claimed counterpoint to RingConn: same form factor + similar capability claims at diametrically opposite verification posture; canonical framework worked example.
• Commercially active across 48 states: $60M Series A August 2022 + OpenLoop + EnsoData service infrastructure (CORRECTED from "quiet since 2022" per Agent A re-verify).
• Multiple cap-flags: 97% PSG company-reported (no peer-reviewed citation); "brain biometrics" UNSUBSTANTIATED by named EEG hardware.

Contrast with cohort:

• RingConn (Gen 2 / Gen 3): subscription-free $279; AHI 90.7%-claimed but NOT FDA-cleared; sharp verified-vs-claimed counterpoint.
• Ultrahuman Ring (Air / Pro): hardware + subscription-augmented; AFib via FibriCheck third-party (NOT native cleared).
• Oura Ring: purchase + membership; ITC '178 patent holder.
• Whoop: subscription-only band; BP Insights FDA Warning Letter dispute unresolved.

For the canonical biometric cluster context, see the biometric cluster. For the within-cohort verified-vs-claimed counterpoint, see what is RingConn. For the canonical category umbrella, see what is physical AI. For methodology canonical references applicable to Happy Ring: verified-vs-claimed at within-entity granularity (CANONICAL dual FDA clearances within-entity verification posture) + the 9-tier source-quality rubric (FDA dual-clearance primary-government-record source classification).